Xenon Pharmaceuticals XENE
NASDAQ XENE
$41.39 +0.94 (+2.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Xenon Pharmaceuticals (XENE) Net Long-Term Debt Issued (Repaid) (2018)

Updated

Xenon Pharmaceuticals' Net Long-Term Debt Issued (Repaid) came in at $8.45 million for FY2018, up 22.6% from $6.89 million in FY2017.

Analysis

Xenon Pharmaceuticals (XENE) Net Long-Term Debt Issued (Repaid) (2018) Analysis & Trends

  • Per Business Quant, earlier years put Net Long-Term Debt Issued (Repaid) at $6.89 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Xenon Pharmaceuticals 4.06 Bn 1.03 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 3.46 Mn
API Access

Xenon Pharmaceuticals Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=XENE&period=max&api_key=YOUR_API_KEY